John J Georrge

Dr. John J Georrge


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2017 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
CPChirag N. Patel
Chirag N. Patel
JGJohn J Georrge
John J Georrge
KMKrunal M. Modi
Krunal M. Modi
MNMoksha B. Narechania
Moksha B. Narechania
DPDaxesh P. Patel
Daxesh P. Patel
HPHimanshu A. Pandya
Himanshu A. Pandya
Alzheimer’s disease (AD) is one of the most significant neurodegenerative disorders and its symptoms mostly appear in aged people. Catechol-o-methyltransferase (COMT) is one of the known target enzymes responsible for AD. With the use of 23 known inhibitors of COMT, a query has been generated and validated by screening against the database of 1500 decoys to obtain the GH score and enrichment value. The crucial features of the known inhibitors were evaluated by the online ZINC Pharmer to identify new leads from a ZINC database. Five hundred hits were retrieved from ZINC Pharmer and by ADMET (absorption, distribution, metabolism, excretion, and toxicity) filtering by using FAF-Drug-3 and 36 molecules were considered for molecular docking. From the COMT inhibitors, opicapone, fenoldopam, and quercetin were selected, while ZINC63625100_413 ZINC39411941_412, ZINC63234426_254, ZINC63637968_451, and ZINC64019452_303 were chosen for the molecular dynamics simulation analysis having high binding affinity and structural recognition. This study identified the potential COMT inhibitors through pharmacophore-based inhibitor screening leading to a more complete understanding of molecular-level interactions.

11 October 2014 in Journal of Cheminformatics
Verified
Journal Article
Open access
PDF file
ASArun Sharma
Arun Sharma
PDPrasun Dutta
Prasun Dutta
MSManeesh Sharma
Maneesh Sharma
NRNeeraj Kumar Rajput
Neeraj Kumar Rajput
BDBhavna Dodiya
Bhavna Dodiya
OCOSDD Consortium
OSDD Consortium
Background: Tuberculosis (TB) is the second leading cause of death from a single infectious organism, demanding attention towards discovery of novel anti-tubercular compounds. Natural products or their derivatives have provided more than 50% of all existing drugs, offering a chemically diverse space for discovery of novel drugs. Description: BioPhytMol has been designed to systematically curate and analyze the anti-mycobacterial natural product chemical space. BioPhytMol is developed as a drug-discovery community resource with anti-mycobacterial phytomolecules and plant extracts. Currently, it holds 2582 entries including 188 plant families (692 genera and 808 species) from global flora, manually curated from literature. In total, there are 633 phytomolecules (with structures) curated against 25 target mycobacteria. Multiple analysis approaches have been used to prioritize the library for drug-like compounds, for both whole cell screening and target-based approaches. In order to represent the multidimensional data on chemical diversity, physiochemical properties and biological activity data of the compound library, novel approaches such as the use of circular graphs have been employed. Conclusion: BioPhytMol has been designed to systematically represent and search for anti-mycobacterial phytochemical information. Extensive compound analyses can also be performed through web-application for prioritizing drug-like compounds. The resource is freely available online at http://ab-openlab.csir.res.in/biophytmol/.

21 March 2012 in Applied Biochemistry and Biotechnology
Verified
Journal Article
Closed access
PDF file
LJLijo John
Lijo John
JGJohn J Georrge
John J Georrge
TKTrupti Kholia
Trupti Kholia

1 July 2019 in Arabian Journal of Chemistry
Verified
Journal Article
Open access
RSRina Soni
Rina Soni
SDSunil Dutt Durgapal
Sunil Dutt Durgapal
SSShubhangi S. Soman
Shubhangi S. Soman
JGJohn J Georrge
John J Georrge

23 December 2014 in Journal of Applied Genetics
Verified
Journal Article
Closed access
PDF file
NVNishita Vaishnav
Nishita Vaishnav
AGAparna Gupta
Aparna Gupta
SPSneha Paul
Sneha Paul
JGJohn J Georrge
John J Georrge

3 December 2020 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
PDF file
Hedmon OkellaHedmon Okella
Hedmon Okella
JGJohn J Georrge
John J Georrge
SOSylvester Ochwo
Sylvester Ochwo
CNChristian Ndekezi
Christian Ndekezi
KKKevin Tindo Koffi
Kevin Tindo Koffi
POPatrick Engeu Ogwang
Patrick Engeu Ogwang
Antimicrobial resistance remains a great threat to global health. In response to the World Health Organizations’ global call for action, nature has been explored for novel and safe antimicrobial candidates. To date, fish have gained recognition as potential source of safe, broad spectrum and effective antimicrobial therapeutics. The use of computational methods to design antimicrobial candidates of industrial application has however, been lagging behind. To fill the gap and contribute to the current fish-derived antimicrobial peptide repertoire, this study used Support Vector Machines algorithm to fish out fish-antimicrobial peptide-motif candidates encrypted in 127 peptides submitted at the Antimicrobial Peptide Database (APD3), steered by their physico-chemical characteristics (i.e., positive net charge, hydrophobicity, stability, molecular weight and sequence length). The best two novel antimicrobial peptide-motifs (A15_B, A15_E) with the lowest instability index (−28.25, −22.49, respectively) and highest isoelectric point (pI) index (10.48 for each) were selected for further analysis. Their 3D structures were predicted using I-TASSER and PEP-FOLD servers while ProSA, PROCHECK, and ANOLEA were used to validate them. The models predicted by I-TASSER were found to be better than those predicted by PEP-FOLD upon validation. Two I-TASSER models with the lowest c-score of −0.10 and −0.30 for A15_B and A15_E peptide-motifs, respectively, were selected for docking against known bacterial-antimicrobial target-proteins retrieved from protein databank (PDB). Carbapenam-3-carboxylate synthase (PDB ID; 4oj8) yielded the lowest docking energy (−8.80 and −7.80 Kcal/mol) against motif A15_B and A15_E, respectively, using AutoDock VINA. Further, in addition to Carbapenam-3-carboxylate synthase, these peptides (A15_B and A15_E) were found to as well bind to membrane protein (PDB ID: 1by3) and Carbapenem synthetase (PDB: 1q15) when ClusPro and HPEPDOCK tools were used. The membrane protein yielded docking energy scores (DES): −290.094, −270.751; coefficient weight (CW): −763.6, 763.3 for A15_B and A15_E) whereas, Carbapenem synthetase (PDB: 1q15) had a DES of −236.802, −262.75 and a CW of −819.7, −829.7 for peptides A15_B and A15_E, respectively. Motif A15_B of amino acid positions 2–19 in Pleurocidin exhibited the strongest in silico antimicrobial potentials. This segment could be a good biological candidate of great application in pharmaceutical industries as an antimicrobial drug candidate.